Skip to main content

Published locations for Pembrolizumab shows signs of efficacy in relapsed/refractory classical Hodgkin lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Pembrolizumab shows signs of efficacy in relapsed/refractory classical Hodgkin lymphoma

User login

  • Reset your password
  • /content/pembrolizumab-shows-signs-efficacy-relapsed/refractory-classical-hodgkin-lymphoma
  • /hematologynews/article/110149/aggressive-lymphomas/pembrolizumab-shows-signs-efficacy-relapsed
  • /oncologypractice/article/110149/aggressive-lymphomas/pembrolizumab-shows-signs-efficacy-relapsed
  • /hematologynews/nhlhub/article/110149/aggressive-lymphomas/pembrolizumab-shows-signs-efficacy
  • /hematology-oncology/article/110149/aggressive-lymphomas/pembrolizumab-shows-signs-efficacy-relapsed